Product Name |
Gliclazide EP Impurity G |
Alternate Names |
Gliclazide Impurities, Impurities of Gliclazide |
CAT No. |
CS-O-20057
|
CAS No. |
Not Available |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
321.39 g/mol |
Mol. For. |
C₁₅H₁₉N₃O₃S
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Gliclazide |
Purity |
95% |
Therapeutic |
Anti-Diabetic |
Smileys |
O=C(N[S](=O)(C1=CC=C(C)C=C1)=O)NN2N=CC(CCC3)C3C2 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Gliclazide EP Impurity G is a chemical compound that is commonly used as a reference standard or impurity in the pharmaceutical industry. It is a byproduct or intermediate in the synthesis of Gliclazide, an oral hypoglycemic agent used for the treatment of type 2 diabetes.
The chemical name of Gliclazide EP Impurity G is 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazoline-5-one. It is a yellow colored crystalline powder that is sparingly soluble in water and soluble in organic solvents. The molecular formula of Gliclazide EP Impurity G is C11H12N2O, and its molecular weight is 188.23 g/mol.
The usage of Gliclazide EP Impurity G is primarily for analytical purposes. It is used as a reference standard to identify and quantify impurities present in Gliclazide drug substance or drug product. It is also used in the development of analytical methods for the determination of Gliclazide and its related substances in pharmaceutical formulations.
The chemical information of Gliclazide EP Impurity G is important for the pharmaceutical industry to ensure the safety and efficacy of Gliclazide drug products. The presence of impurities in drug substances or drug products can affect the quality, potency, and safety of the drug. Therefore, the identification and quantification of impurities are critical in the development and manufacturing of pharmaceutical products.